EANM guideline on quality risk management for radiopharmaceuticals.

Nic GillingsOlaug HjelstuenMartin BeheClemens DecristoforoPhilip H ElsingaValentina FerrariOliver C NeelsPetra KolencJacek KoziorowskiPeter LavermanThomas L MindtMeltem OcakMarianne PattSergio ToddeAlmut Walte

Published in: European journal of nuclear medicine and molecular imaging (2022)

This document is intended as a supplement to the EANM "Guidelines on current Good Radiopharmacy Practice (cGRPP)" issued by the Radiopharmacy Committee of the EANM (Gillings et al. in EJNMMI Radiopharm Chem. 6:8, 2021). The aim of the EANM Radiopharmacy Committee is to provide a document that describes how to manage risks associated with small-scale "in-house" preparation of radiopharmaceuticals, not intended for commercial purposes or distribution.

Keyphrases

healthcare
primary care
quality improvement
clinical practice
human health
risk assessment
climate change
molecularly imprinted